Evening Reception

Exclusively for Life Sciences Decision-Makers

Wednesday, July 26th | 4:00 - 5:00 p.m.

Brought to you by:

Please use the button above to indicate your interest in attending this event, and we will reach out to confirm your acceptance.

Registration is FREE but highly exclusive!

By applying, you consent to subscribing to the DxPx Newsletter and receiving marketing emails about upcoming DxPx Conferences and our in-house pitch competition, 42PLUS1.

AdvaMed’s member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Their members produce health care technology both in the United States and around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies.

AdvaMed advocates for a legal, regulatory and economic environment that advances global health care by assuring worldwide patient access to the benefits of medical technology. They promote policies that foster the highest ethical standards, rapid product approvals, appropriate reimbursement, and access to international markets.

ray briscuso advamed
Ray Briscuso, Executive Vice President of Conferences & Events for the Advanced Medical Technology Association

The DxPx Cocktail Reception:
A Must-Attend Event for Startups, Investors & Strategics

We are excited to announce that our highly anticipated cocktail reception will be held on the second day of the DxPx conference, July 26th, from 4:00 – 5:00 p.m.

Register now to secure your spot at this exclusive event, where groundbreaking ideas and transformative partnerships come together.

Benefits Include:

  • Free Admission: Complimentary registration for the cocktail reception allows you to maximize your conference networking experience at no additional cost.
  • Centralized Location: Because the cocktail reception is being held within the ADLM, you can quickly and easily transition from conference sessions right to the reception.
  • Unparalleled Networking: Mingle with a diverse range of peers, thought leaders, and experts from the diagnostics, digital health, life sciences, and precision medicine fields.
  • Convenient Timing: The reception will take place from 4:00 – 5:00 p.m., offering a prime slot in your conference schedule at the end of the second day to unwind, engage in meaningful conversations, and forge new professional relationships.

Explore the complete DxPx US agenda:

DxPx US 2023

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience